Kayentis Launches Platform for DCTs


Kayentis announced the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and decentralized clinical trials (DCT).

This streamlined platform alleviates many logistical hurdles in bringing key elements of the clinical trial to patients’ homes, while vastly improving how patients and sites use DCT technologies.

Read more about Kayentis' new platform here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.